“FDA approved” is one of the most-misused phrases in the supplement industry. The FDA does not approve dietary supplements. It approves drugs. What it does for supplements is something else entirely, and the difference is worth understanding before you trust a label that leans on those two words.
What FDA registration actually is
Under section 415 of the U.S. Federal Food, Drug, and Cosmetic Act, every facility that manufactures, processes, packs, or holds food (including dietary supplements) for U.S. consumption must register with the FDA. This is a registration, not an approval.
Our facility holds FDA Registration No. 14287957814. That means the U.S. government knows our address and our scope of activity, and has the authority to inspect us under the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act (FSMA) of 2011.
What it does NOT mean
- It does not mean the FDA has tested or approved any of our products.
- It does not mean any specific dietary supplement we make has been evaluated.
- It does not mean we are exempt from compliance obligations, the opposite, we are obligated.
You will not see “FDA approved” on a label we print, because nobody is entitled to print it on a supplement. The accurate phrasing is that the manufacturer is FDA registered. Wording matters here, and a brand that gets it wrong on the front of the bottle is telling you something about the rest of its file.
21 CFR Part 111: the cGMP we work under
The real compliance backbone is FDA’s 21 CFR Part 111, the current Good Manufacturing Practice for dietary supplements. It covers:
- Personnel hygiene and training
- Physical plant and equipment
- Production and process controls
- Quality control with written specifications
- Holding and distribution records
- Returned dietary supplements protocols
- Consumer complaint handling
We are audited under these standards. The result of that audit, alongside ISO 22000 and ISO 22716, is a documented quality system, and it is the same one standing behind every bottle we sell.
The obligations that sit with the brand, not the plant
Facility registration and cGMP cover the building. A second set of U.S. obligations sits with the brand owner of record, the company whose name is on the bottle. In most of this industry those are two different companies, and the seam between them is where problems hide. We manufacture only what we sell, so both sets land on the same desk:
- Label compliance. The Supplement Facts panel, claims, ingredient declarations, the name and address of the responsible company.
- Structure/function claims with disclaimer. Any function claim carries the standard FDA disclaimer.
- NDIN filing for any new dietary ingredient that was not marketed in the U.S. before October 15, 1994. We draft and file these ourselves, in our own name.
- Adverse event reporting. 21 CFR Part 4 requires a system for receiving and reporting serious adverse events within 15 business days. Ours runs in house, which means a complaint reaches the people who made the batch.
FSMA and the supply chain
The Food Safety Modernization Act extended FDA’s reach to imports. Every shipment into the U.S. requires FDA Prior Notice, typically 4–8 hours before arrival, plus full FSMA-compliant documentation. We file it on every shipment. If the paperwork is wrong the container sits at the port, and there is nobody else for that to be a problem for.
What the timeline actually looks like
| Step | Time |
|---|---|
| Confirm formulation contains no NDIs | 2–3 days |
| Label design with Supplement Facts | 5–7 days |
| FDA Prior Notice for first shipment | same week |
| Customs clearance to U.S. warehouse | 5–7 days from departure |
Realistic time from a locked formulation to product sitting in a U.S. warehouse, for a standard formula: about 30 days. None of that is the FDA approving anything. It is documentation, testing and logistics, done in the right order.